![](/img/cover-not-exists.png)
PRS45 - COST-EFFECTIVENESS OF BEDAQUILINE VERSUS INJECTABLE STANDARD-OF-CARE AGENTS FOR THE TREATMENT OF DRUG-RESISTANT TUBERCULOSIS (DR-TB) IN RUSSIA, INDIA, AND SOUTH AFRICA: BREAKTHROUGH INNOVATION DRIVING DOWN COST OF TREATMENT SUCCESS
Ionescu, A., Agnarson, M.A., Kambili, C., Kfoury, J., Steven, W., Singh, V., Williams, A., Thomas, A.Volume:
21
Journal:
Value in Health
DOI:
10.1016/j.jval.2018.09.2439
Date:
October, 2018
File:
PDF, 381 KB
2018